Home > News > Labopharm reports results for second quarter fiscal 2004
July 28th, 2004
Labopharm reports results for second quarter fiscal 2004
Abstract:
Labopharm Inc. (TSX: DDS) today reported its results for the second quarter of fiscal 2004 ended June 30, 2004. Net loss for the second quarter of fiscal 2004 was $7.1 million, or $0.18 per share, compared with $8.8 million, or $0.28 per share, for the second quarter of fiscal 2003.
Source:
PRNewswire
Related News Press |
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||